Log In
BCIQ
Print this Print this
 

GL-ONC3

  Manage Alerts
Collapse Summary General Information
Company Genelux Corp.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer and other highly vascular tumor types
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today